Laboratory Balances in the Pharmaceutical Industry
Pharmaceutical regulations – including rules for testing and analyzing drugs – must be met when pharma companies want to put their manufactured products on the market. These regulations are outlined in pharmacopeias – e.g. the United States Pharmacopeia (USP) for the US market and the European Pharmacopoeia (Ph.Eur.) for the European market.
While the US Pharmacopeia has featured a chapter on the use of laboratory balances for several years, a respective chapter has only recently been introduced to the Ph.Eur. It became mandatory in January 2022.
This graphic summarizes lab balance regulations according to both pharmacopeias - and highlights the differences between them.
